SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 77 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.24 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $3,767 | +25.6% | 3,924 | 0.0% | 0.00% | – |
| Q1 2023 | $3,000 | +299900.0% | 3,924 | 0.0% | 0.00% | – |
| Q4 2022 | $1 | -100.0% | 3,924 | -66.6% | 0.00% | – |
| Q3 2022 | $5,000 | -85.3% | 11,745 | -73.2% | 0.00% | – |
| Q2 2022 | $34,000 | -94.0% | 43,876 | -90.1% | 0.00% | – |
| Q1 2022 | $571,000 | -8.5% | 441,612 | -10.2% | 0.00% | – |
| Q4 2021 | $624,000 | -45.1% | 491,656 | -5.6% | 0.00% | – |
| Q3 2021 | $1,136,000 | -45.9% | 521,016 | -7.0% | 0.00% | – |
| Q2 2021 | $2,101,000 | +2.9% | 560,220 | -10.6% | 0.00% | – |
| Q1 2021 | $2,042,000 | -5.0% | 626,527 | -0.6% | 0.00% | – |
| Q4 2020 | $2,149,000 | -33.2% | 630,064 | -18.1% | 0.00% | -100.0% |
| Q3 2020 | $3,215,000 | +548.2% | 769,073 | +424.2% | 0.00% | – |
| Q2 2020 | $496,000 | +45.5% | 146,727 | -0.1% | 0.00% | – |
| Q1 2020 | $341,000 | -44.9% | 146,827 | -13.6% | 0.00% | – |
| Q4 2019 | $619,000 | -57.0% | 169,937 | -2.2% | 0.00% | – |
| Q3 2019 | $1,441,000 | -30.4% | 173,751 | -26.9% | 0.00% | – |
| Q2 2019 | $2,069,000 | -16.9% | 237,536 | +2.0% | 0.00% | -100.0% |
| Q1 2019 | $2,489,000 | +17.7% | 232,839 | -3.7% | 0.00% | – |
| Q4 2018 | $2,115,000 | +376.4% | 241,713 | +814.8% | 0.00% | – |
| Q3 2018 | $444,000 | -6.9% | 26,423 | +15.9% | 0.00% | – |
| Q2 2018 | $477,000 | -83.9% | 22,795 | -87.6% | 0.00% | -100.0% |
| Q1 2018 | $2,964,000 | -45.7% | 184,251 | -36.0% | 0.00% | 0.0% |
| Q4 2017 | $5,456,000 | +666.3% | 287,965 | +446.0% | 0.00% | – |
| Q3 2017 | $712,000 | +4646.7% | 52,741 | +2435.6% | 0.00% | – |
| Q2 2017 | $15,000 | +25.0% | 2,080 | +17.2% | 0.00% | – |
| Q1 2017 | $12,000 | +71.4% | 1,775 | +13.8% | 0.00% | – |
| Q4 2016 | $7,000 | – | 1,560 | +2263.6% | 0.00% | – |
| Q2 2016 | $0 | – | 66 | 0.0% | 0.00% | – |
| Q1 2016 | $0 | -100.0% | 66 | -99.9% | 0.00% | – |
| Q3 2013 | $934,000 | -11.3% | 111,453 | -21.0% | 0.00% | – |
| Q2 2013 | $1,053,000 | – | 141,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 787,973 | $615,000 | 0.77% |
| CM Management, LLC | 600,000 | $468,000 | 0.50% |
| ARMISTICE CAPITAL, LLC | 17,100,000 | $13,338,000 | 0.23% |
| Sargent Investment Group, LLC | 614,600 | $479,000 | 0.15% |
| Ergoteles LLC | 744,275 | $581,000 | 0.02% |
| Sonora Investment Management Group, LLC | 103,000 | $80,000 | 0.01% |
| CAXTON ASSOCIATES LP | 107,135 | $84,000 | 0.01% |
| MCDONALD PARTNERS LLC | 42,570 | $33,000 | 0.01% |
| Pinz Capital Management, LP | 15,600 | $12,000 | 0.01% |
| D. E. Shaw & Co., Inc. | 8,051,858 | $6,281,000 | 0.01% |